Sort by
Rebuilding the Antibiotic Pipeline with Guided Generative Models
Shriya Bhat
,Rishab Jain
,Wesley Greenblatt
Posted: 16 January 2026
The Prevention Theorem: Time-Dependent Constraints on Post-Exposure Prophylaxis for HIV
A.C. Demidont
Posted: 14 January 2026
The Synaptic Pruning Cliff: Threshold-Like Network Fragility Under Internal Stress and Efficient Recovery in a Computational Model of Depression
Ngo Cheung
Posted: 13 January 2026
Mechanistic Insights into the Differential Efficacy of Sonratoclax against Venetoclax-Resistant BCL2 G101V
Yashmin Afshar
,Ali Goli
,Melika Abrishami
Posted: 08 January 2026
An Integrative Variant Scoring Function for Finding Novel Genes Associated with Ovarian and Thyroid Cancer
Amanda Bataycan
,Omodolapo Nurudeen
,Jonathon E. Mohl
,Khodeza Begum Mitchell
,Ming-Ying Leung
We devised a quantitative scoring function to assess the cumulative effects of nonsynonymous single nucleotide variants (SNVs) on protein-coding genes in patients with ovarian cancer (OvCa) and thyroid cancer (ThCa). The goal is to find novel candidate cancer-related genes for downstream bioinformatics analyses and wet-lab studies. With Genomic Data Commons as primary data resource, SNV information was extracted from whole-exome sequencing data from patients with these cancers. A cumulative variant scoring function, Q(G) was developed to sum up the deleterious effects of the individual SNVs on the gene G. While Q(G) can be computed using any popular functional effect analyzers such as FATHMM-XF, SIFT, PolyPhen, and CADD, we have also established an integrative scoring function iQ(G) that combines the deleterious assessments from different analyzers and demonstrated that iQ(G) is a more effective method for identifying likely cancer-related genes. Based on the iQ(G) rankings, the top three novel genes for OvCa are AHNAK2, UNC13A, and PCDHB4; and those for ThCA are PLEC, HECTD4, and CES1. Furthermore, the top 1% genes with highest iQ(G) scores for each cancer were submitted for KEGG pathway analysis. The results revealed that several genes of the CACNA1 family within the type II diabetes mellitus pathway are likely related to both OvCa and ThCa and suggested other molecular interactions that should be further studied in connection with OvCa prognosis and ThCa treatment.
We devised a quantitative scoring function to assess the cumulative effects of nonsynonymous single nucleotide variants (SNVs) on protein-coding genes in patients with ovarian cancer (OvCa) and thyroid cancer (ThCa). The goal is to find novel candidate cancer-related genes for downstream bioinformatics analyses and wet-lab studies. With Genomic Data Commons as primary data resource, SNV information was extracted from whole-exome sequencing data from patients with these cancers. A cumulative variant scoring function, Q(G) was developed to sum up the deleterious effects of the individual SNVs on the gene G. While Q(G) can be computed using any popular functional effect analyzers such as FATHMM-XF, SIFT, PolyPhen, and CADD, we have also established an integrative scoring function iQ(G) that combines the deleterious assessments from different analyzers and demonstrated that iQ(G) is a more effective method for identifying likely cancer-related genes. Based on the iQ(G) rankings, the top three novel genes for OvCa are AHNAK2, UNC13A, and PCDHB4; and those for ThCA are PLEC, HECTD4, and CES1. Furthermore, the top 1% genes with highest iQ(G) scores for each cancer were submitted for KEGG pathway analysis. The results revealed that several genes of the CACNA1 family within the type II diabetes mellitus pathway are likely related to both OvCa and ThCa and suggested other molecular interactions that should be further studied in connection with OvCa prognosis and ThCa treatment.
Posted: 07 January 2026
Bayesian Decision-Making Shapes Phenotypic Landscapes from Differentiation to Cancer
Arnab Barua
,Haralampos Hatzikirou
Posted: 05 January 2026
GenProtect-V: A Variational Inference-based Framework for Privacy-Preserving Synthetic Human Genomic Data Generation
Zihan Bian
,Linyu Mou
Posted: 29 December 2025
Artificial Intelligence–Driven Structural Mining Enables Functional Inference in the Human Dark Proteome
Valentina Carbonari
,Annamaria Defilippo
,Ugo Lomoio
,Caterina Francesca Perri
,Barbara Puccio
,Pierangelo Veltri
,Pietro Hiram Guzzi
Posted: 23 December 2025
An Agent‐Based Model of Youth Nonmedical Prescription Opioid Use in Ontario: Forecast Validation and Future Projection
Narjes Shojaati
Posted: 19 December 2025
Kappa-Frameshift Background Mutations and Long-Range Correlations of the DNA Base Sequences
Elias Koorambas
Posted: 17 December 2025
Stochastic Modelling and Analysis of Within-Farm Highly Pathogenic Avian Influenza Dynamics in Dairy Cattle
Parul Tiwari
,Malavika Smitha
,Hammed Olawale Fatoyinbo
Posted: 17 December 2025
DNABERT2-CAMP: A Hybrid Transformer-CNN Model for E. coli Promoter Recognition
Hua-Lin Xu
,Xiu-Jun Gong
,Hua Yu
,Ying-Kai Wang
Posted: 17 December 2025
Graph of Life, Borders of Life, and Global Life Network
Valentin E. Brimkov
Posted: 15 December 2025
Fuzzy Logic–Integrated Optimal Control for Dynamic Intervention in Hepatitis C Virus Epidemiology
Debnarayan Khatua
,Bikash Kumar
,Manoranjan K. Singh
,Somnath Kumar
Posted: 14 December 2025
Real-Time Nanopore Methylome Profiling Identifies CpG-Poor Transcription Factor Regions as Epigenetic Signatures of Relapse in Acute Myeloid Leukemia
Gabriela Fernandes
Relapse in acute myeloid leukemia (AML) is frequently associated with chemoresistance, yet the molecular mechanisms driving this transition remain incompletely understood. To explore relapse-associated epigenetic remodeling, we reanalyzed publicly available Nanopore whole-genome methylation data from three AML patients with matched onset and relapse samples. We focused on CpG-poor transcription factor (TF)-associated regulatory regions, recently implicated as unconventional epigenetic hotspots in leukemia progression. Across all samples, relapse was characterized by a consistent gain in DNA methylation within CpG-poor TF regions, with all ranked loci demonstrating a positive mean Δβ shift. Heatmap visualization of the top-ranked regions revealed distinct clustering of relapse versus onset samples, supporting the presence of a coordinated epigenetic signature rather than random methylation drift. These findings suggest that relapse AML cells may acquire targeted methylation to suppress key regulatory networks involved in DNA repair, apoptosis, and growth control, thereby enabling therapeutic escape. This work highlights the potential utility of Nanopore methylation profiling as a real-time biomarker platform to detect relapse-associated epigenetic rewiring and guide precision treatment strategies.
Relapse in acute myeloid leukemia (AML) is frequently associated with chemoresistance, yet the molecular mechanisms driving this transition remain incompletely understood. To explore relapse-associated epigenetic remodeling, we reanalyzed publicly available Nanopore whole-genome methylation data from three AML patients with matched onset and relapse samples. We focused on CpG-poor transcription factor (TF)-associated regulatory regions, recently implicated as unconventional epigenetic hotspots in leukemia progression. Across all samples, relapse was characterized by a consistent gain in DNA methylation within CpG-poor TF regions, with all ranked loci demonstrating a positive mean Δβ shift. Heatmap visualization of the top-ranked regions revealed distinct clustering of relapse versus onset samples, supporting the presence of a coordinated epigenetic signature rather than random methylation drift. These findings suggest that relapse AML cells may acquire targeted methylation to suppress key regulatory networks involved in DNA repair, apoptosis, and growth control, thereby enabling therapeutic escape. This work highlights the potential utility of Nanopore methylation profiling as a real-time biomarker platform to detect relapse-associated epigenetic rewiring and guide precision treatment strategies.
Posted: 02 December 2025
Reaction–Diffusion Model of CAR-T Cell Therapy in Solid Tumours with Antigen Escape
Maxim Valentinovich Polyakov
,Elena Ivanovna Tuchina
Posted: 02 December 2025
Predicting the Onset of Type 2 Diabetes (T2D) Based on Genetic and Clinical Risk Factors Using XGBoost ML Model
Arnav Gupta
,Gatik Goyal
Posted: 26 November 2025
An Intelligent Decision-Support Framework for AST Risk Prediction Using Explainable Ensemble Learning
Natalya Maxutova
,Akmaral Kassymova
,Kuanysh Kadirkulov
,Aisulu Ismailova
,Gulkiz Zhidekulova
,Zhanar Azhibekova
,Jamalbek Tussupov
,Quvvatali Rakhimov
,Zhanat Kenzhebayeva
Posted: 18 November 2025
Variational Quantum Eigensolver for Clinical Biomarker Discovery: A Multi-Qubit Model
Juan Pablo Acuña González
,Moisés Sánchez Adame
,Oscar Montiel
Posted: 13 November 2025
ML-Based Optimal Design of One-Component Ionizable Amphiphilic Janus Dendrimers for Enhanced Dendrimersome Nanoparticle-Mediated mRNA Delivery
Joshua Kim
,Sungwoo Yang
Posted: 30 October 2025
of 13